Pediatrix Medical Group, Inc. (MD)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-04) · 99.1 | 8-K (2026-07-15) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-05) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-19) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-03) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-20) · 99.1 | 8-K (2025-01-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-01) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-06) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-07) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-20) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Income and Comprehensive Income | ||
| Condensed Consolidated Statements of Income (P) | — |
|
| Consolidated Statements of Income and Comprehensive Income (P) | ||
| Consolidated Statements of Equity | ||
| Consolidated Statements of Shareholders' Equity (unaudited) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accounts Payable and Accrued Expenses | ||
| Accounts Receivable and Net Revenue | ||
| Accrued Professional Liabilities | — |
|
| Basis of Presentation | — |
|
| Basis of Presentation and New Accounting Pronouncements | — |
|
| Business Combinations | ||
| Cash Equivalents and Investments | — |
|
| Commitments and Contingencies | ||
| Common and Common Equivalent Shares | ||
| Common Stock Repurchase Programs | ||
| Coronavirus Pandemic ("covid")-19 and The Cares Act | — |
|
| Coronavirus Pandemic (covid-19) | — |
|
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Discontinued Operations | — |
|
| Discontinued Operations and Loss On Disposal of Businesses | — |
|
| Divestitures | ||
| Exhibits and Financial Statement Schedule | — |
|
| Fair Value Measurements | — |
|
| General | — |
|
| Goodwill | — |
|
| Goodwill and Intangible Assets | — |
|
| Goodwill and Long-lived Asset Impairments | — |
|
| Goodwill, Long Lived Asset Impairments and Loss On Disposal of Businesses | — |
|
| Goodwill, Long-lived Asset Impairments and Loss On Disposal of Businesses | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Investments | — |
|
| Line of Credit and Long Term Debt | — |
|
| Line of Credit, Long-term Debt and Finance Lease Obligations | — |
|
| Operating Leases | — |
|
| Pay Vs Performance Disclosure | ||
| Property and Equipment | — |
|
| Retirement Plans | — |
|
| Segment Reporting | — |
|
| Short-term Investments | — |
|
| Stock Incentive Plans and Stock Purchase Plans | ||
| Summary of Significant Accounting Policies | — |
|